Abbott launches its first over-the-counter continuous glucose monitor in the U.S.
Abbott Laboratories announced Lingo, its first over-the-counter continuous glucose monitor, is available in the U.S.
| Ticker |
Sentiment |
Impact |
|
NKE
|
Somewhat Bearish
|
4 %
|
|
NVDA
|
Somewhat Bullish
|
4 %
|
|
ABT
|
Neutral
|
4 %
|
|
ULTA
|
Bullish
|
4 %
|
|
DXCM
|
Neutral
|
4 %
|
